|
HS Code |
311915 |
| Product Name | 2-Bromo-6-Trifluoromethyl-3-Aminopyridine |
| Cas Number | 884494-37-7 |
| Molecular Formula | C6H4BrF3N2 |
| Molecular Weight | 241.01 g/mol |
| Appearance | Off-white to light yellow solid |
| Melting Point | 55-58°C |
| Purity | ≥98% |
| Solubility | Soluble in DMSO and DMF |
| Smiles | C1=CC(=NC(=C1Br)N)C(F)(F)F |
| Inchi | InChI=1S/C6H4BrF3N2/c7-4-2-3(6(8,9)10)1-5(11)12-4/h1-2H,(H2,11,12) |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Synonyms | 2-Bromo-6-(trifluoromethyl)pyridin-3-amine |
As an accredited 2-Bromo-6-Trifluoromethyl-3-Aminopyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Bromo-6-Trifluoromethyl-3-Aminopyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Sometimes a molecule offers more than its name might suggest. 2-Bromo-6-Trifluoromethyl-3-Aminopyridine, with a sharp-sounding structure, comes from the class of substituted aminopyridines. Its design—an aromatic core with bromine and trifluoromethyl groups alongside an amine—introduces unique reactivity and selectivity in chemical development that experienced chemists notice right away. My time in the lab taught me that the smallest changes to a molecule’s framework often make the biggest differences in downstream applications, especially in medicinal chemistry or agrochemical research.
Let’s look at the specifics that shape this compound’s value. With the molecular formula C6H4BrF3N2, it stands out owing to three strong features: a bromine atom at the 2-position, a trifluoromethyl group at the 6-position, and an amino group at the 3-position on a pyridine ring. The juxtaposition of electron-withdrawing and electron-donating groups alters the electron density across the ring. This shifts reaction sites, making the molecule more than a sum of its parts. It’s these subtle chemical shifts that make a difference in targeted synthesis.
Working on small-molecule drug candidates, I came to respect what fluorine atoms—especially those in a trifluoromethyl configuration—bring to the table. They not only enhance metabolic stability but also influence the molecule’s polarity, lipophilicity, and ability to traverse biological membranes. Certain structures, including trifluoromethyl groups, improve bioavailability or slow breakdown in the liver. Medicinal chemists, including myself, often seek out such features for library design or final drug optimization.
Each shipment of this compound comes as a pure crystalline solid, usually off-white to light yellow in color. Purity levels often reach up to 98% or more by HPLC, which aligns with the quality needed for lab-scale synthesis. The melting point sits comfortably above common storage temperatures, so the compound maintains stability under typical storage conditions. In practice, I never noticed any significant decomposition or loss of reactivity, provided normal standards for chemical storage are observed.
The scenarios where 2-Bromo-6-Trifluoromethyl-3-Aminopyridine finds value stem from its balance of substitution. Bromine on the pyridine ring makes this compound a reliable partner for cross-coupling reactions. For example, a Suzuki-Miyaura or Buchwald-Hartwig amination can swap the bromine for a new group under mild conditions, which makes the compound a useful intermediate when quickly building complex libraries.
I found that the amino group at the 3-position expands the range of synthetic manipulations. Chemists favor nucleophilic aromatic substitution or use reductive amination—methods that benefit from the amine’s presence. Functional group compatibility on this pyridine variant opens paths to newer heterocyclic scaffolds, which are key in developing advanced pharmaceuticals and crop-protection agents. This isn’t just textbook chemistry; I’ve run library syntheses where a substituted aminopyridine seed unlocked several hit compounds that outperformed those based on naked pyridine or less-applied substitutions.
Molecules like 2-Bromo-6-Trifluoromethyl-3-Aminopyridine often see demand in sectors where selectivity, metabolic resilience, and synthetic flexibility decide the outcome of months-long research programs. In medicinal chemistry, adding fluorine or a trifluoromethyl group sharpens a molecule’s edge against enzymatic degradation. Structural surveys show that 20–25% of small-molecule drugs now on the market contain at least one fluorinated group, reflecting how these changes affect pharmacodynamics and pharmacokinetics.
I’ve also witnessed colleagues in ligand design, searching for scaffolds that hold specific geometry or hydrogen-bonding patterns. The amine group helps create chelation points or enables branching to more complicated side-chains. Bromopyridine analogs have carved a space for themselves as critical intermediates in biaryl construction. The 2-position bromine makes precision couplings possible, while the 6-position CF3 group shifts reactivity in ways that simple methyl or halogen groups do not. The sum total: this molecule offers unique combinations not readily achieved with other building blocks.
Broadly speaking, the world of substituted pyridines is vast. Some contain only halogens; others bring in nitro, methyl, or carboxyl groups. In practice, simple 2-bromopyridine serves well for many reactions, but adding an amine at the 3-position and CF3 at the 6-position presents new reactivity and selectivity patterns. Scientists working on heterocycle diversification—those key moments when a medicinal chemist aims for untapped chemical space—frequently pick molecules with these kinds of substitutions.
The presence of both an electron-donating amino group and an electron-withdrawing trifluoromethyl raises interesting effects. Compared to 2-bromo-3-aminopyridine, which lacks the CF3 group, this compound slows certain side-reactions and increases resistance to oxidative degradation. On the other hand, typical 2,6-dibromopyridine falls short on reactivity diversity, and simple trifluoromethylated pyridines lack easy functional handles for further elaboration. I learned firsthand that these nuanced differences often decide which analogs get advanced in a project pipeline.
Acquiring rare building blocks like 2-Bromo-6-Trifluoromethyl-3-Aminopyridine used to be a bottleneck. Few suppliers produce these molecules at scale, and reliability sometimes wavered years ago. I met these obstacles more than once, especially on projects with tight synthesis timelines. Over the years, improvements in manufacturing and global supply chains have eased some of those hurdles. Companies now pursue greener chemistry and higher throughput, leading to better access and sustainability.
Chemical waste management remains a pressing issue. Pyridine derivatives sometimes find their way into streams or soil without proper processing. Responsible sourcing and improved laboratory practices can cut this risk. As a chemist, I’ve worked with colleagues to implement solvent recovery, on-site neutralization, and batch tracking, reducing hazardous byproducts and their environmental impact. The trifluoromethyl group, for all its advantages, brings challenges for environmental breakdown, so adopting safer protocols matters.
Handling the compound itself rarely presents bother under routine conditions. Goggles, gloves, solid balance, and fume-hood work are standard, with suitable waste disposal. In multi-gram scale-ups, ensuring ventilation and tracking airborne particulates remains best practice, especially as pyridines can present respiratory hazards in poorly controlled environments.
The steady interest in 2-Bromo-6-Trifluoromethyl-3-Aminopyridine comes from demand for ever-more selective and robust molecules in pharmaceutical research. Structure-based drug design thrives on small but purposeful tweaks to starting materials. Medicinal chemistry as a field emphasizes fine-tuning physicochemical properties to balance absorption, distribution, metabolism, and excretion—an area where this molecule’s lineup of groups really shines.
In my experience, structure–activity relationships often pivot on the nature and position of halogen and amine groups. Substituting chlorines or methyls for bromine and CF3 often produces subtle but crucial changes in both reactivity and final biological effect. Projects aiming for kinase inhibitors or CNS-active compounds, for instance, make extensive use of aminopyridines with strategic functionalization.
Another sphere, agrochemical innovation, prioritizes both selective toxicity and crop resilience. Pyridine-based herbicides or fungicides take advantage of such selective scaffolds; a single trifluoromethyl or amine group can tilt activity toward key pest species and away from non-target organisms. Crop chemists I know often look for optimized balance between activity, breakdown, and environmental safety, using these structures as a template for further exploration.
In the years since I started researching pyridines, I noticed a growth not only in availability but also in the types of molecules offered. What used to be available in milligram samples for academic work now arrives by the kilogram for industrial scale-up. Synthetic pathways continue to improve, centered on greener reagents and recyclable solvents. Flow chemistry and continuous reaction platforms promise to increase both safety and yield while reducing cost. I’ve observed technology pushing down lead times, expanding access beyond developed research hubs.
There remains room to sharpen quality control and batch traceability. Analytical data—such as detailed NMR, MS, and HPLC profiles—help ensure that carefully designed chemistry isn’t derailed by a batch-to-batch shift in impurity profiles. In my last lab, routine in-house verification saved several projects from late-stage failure after catching minor contamination, not visible without meticulous records.
Success in chemical research balances technical know-how with organizational memory. I’ve benefited from open-source repositories and collaborative project reviews, which brought together expertise across continents. Best practices around 2-Bromo-6-Trifluoromethyl-3-Aminopyridine haven’t changed much—proper storage, considered waste handling, and awareness of the regulatory landscape remain at the core. Sharing new reaction conditions or purification strategies, whether online or in publishing, strengthens collective capability and safety.
As chemists, we tread carefully, recognizing both the utility and the risks tied to unique reagents. Responsible stewardship—tracking shelf life, monitoring exposure, and upholding sustainability—builds trust throughout supply chains. Real progress often comes from steady, pragmatic attention to the workflow, not just cutting-edge experimentation.
Looking back, the story of advanced aminopyridines weaves together progress in synthesis, analysis, and application. Researchers who take the time to understand such compounds—reading peer-reviewed studies, working through pilot syntheses, and benchmarking against simpler analogs—deliver stronger outcomes. Regular review of primary literature helps cut through marketing overstatements to the real impact on drug pipeline or agrochemical prototype performance.
Personal conversations with other scientists, whether over conference tables or lab benches, add vital granularity to published facts. Discussing what worked—and what failed—with 2-Bromo-6-Trifluoromethyl-3-Aminopyridine in different coupling reactions uncovered techniques that never make it into journals. The value of deliberate, methodical experimentation builds credibility for any novel application, much more than bold claims or rushed pursuits.
With every research season, the pressures change. Speed, innovation, ecological stewardship, and regulatory compliance all intersect over the use of specialty intermediates. 2-Bromo-6-Trifluoromethyl-3-Aminopyridine stands at this intersection—not as a commodity but as a tool for pushing boundaries in molecular design. The combination of functional groups enables access to molecules that were once off-limits or infeasible. Efficient, selective reactions also conserve both resources and researcher time, directly impacting the feasibility of early-stage synthesis in small labs without high-throughput automation.
Companies and academic groups alike continue searching for smarter modular assembly strategies. Routine use of cross-coupling and functional group exchange on molecules like this can trim timelines by weeks. The best results come from a philosophy that values patience, thorough characterization, and readiness to troubleshoot at every step.
Ongoing challenges don’t end at buying a bottle off the shelf. Shipping restrictions, pricing fluctuations, and customs delays often push project timelines off course. Forming professional relationships with suppliers, maintaining a scientific dialogue, and keeping alternate routes open can buffer setbacks. On larger projects, strategic stocking and collaborative purchasing among research groups stretch budgets and encourage knowledge-sharing around quality and performance.
Professional organizations and government bodies now pay closer attention to the environmental fate and safety profile of advanced fluorinated and halogenated organics. As new regulations emerge, staying current with guidance from ICH, EPA, and REACH helps laboratories plan responsibly. I’ve seen implementation of in situ monitoring and greener process chemistry gain favor as a response—not only meeting regulatory demands but reducing operational risk.
As more companies pivot to “green by design” strategies, supply of these compounds should remain steady even as oversight increases. Solvent swaps and catalytic methods continue to shrink the environmental footprint for both production and downstream processing. Programs encouraging the recycling of residual organics and solvents have met early success in many labs, further reducing waste without sacrificing productivity.
Wider use of specialized intermediates like 2-Bromo-6-Trifluoromethyl-3-Aminopyridine depends on effective training and clear protocols. In academic settings, hands-on mentorship speeds skill acquisition and ensures safe, successful syntheses. Many organizations now offer webinars or short courses focused on best practice for handling halogenated and fluorinated reagents. These resources grew out of collective recognition that well-informed chemists make fewer mistakes and enter new research areas with more confidence.
Peer-reviewed journals and shared databases provide up-to-date reaction conditions and application case-studies. The research community benefits from open communication and the readiness to share both success stories and learning moments from difficult experiments. This transparency strengthens project outcomes and speeds adoption of new chemistry, from discovery to manufacturing scale.
Looking beyond the specifications, 2-Bromo-6-Trifluoromethyl-3-Aminopyridine represents the subtlety and discipline that defines modern chemical research. In fifty-gram increments or in pilot-scale kilo lots, its true value rewards hands-on practitioners who learn what makes a difference at the bench. Its unique set of functional groups expands creative possibilities, letting scientists test, iterate, and achieve breakthroughs in industries that shape health and nutrition around the globe. Working firsthand with advanced pyridine intermediates, I saw how discoveries once out of reach come closer with each carefully chosen building block. The work continues—one thoughtful synthesis at a time.